PCA6- COST-EFFECTIVENESS OF GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREATIC CANCER
Jan 1, 1999, 00:00 AM
10.1016/S1098-3015(11)70094-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)70094-8/fulltext
Section Title :
Section Order :
32
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70094-8&doi=10.1016/S1098-3015(11)70094-8